Proton therapy and liver transplant for hilar bile duct cancer
Part of Cancer clinical trials.
This trial tests whether combining proton beam therapy (a precise type of radiation) with a liver transplant can help people with a certain bile duct cancer (hilar cholangiocarcinoma). It may be a new option for those who cannot have surgery to remove the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of bile duct cancer called hilar cholangiocarcinoma that cannot be removed with surgery.
- You are 17 years old or older.
- You are well enough to have a liver transplant (your doctor will check this).
- The cancer is small (less than 3 cm) and has not spread to other organs or lymph nodes.
- You have not had radiation to the upper belly area before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of immunotherapy (tislelizumab), radiation, and chemotherapy before surgery for people with bile duct cancer that is hard to remove. The goal is to shrink the tumor enough to allow successful surgery.
This trial tests a combination of radiation therapy (PULSAR), immunotherapy, and chemotherapy for advanced bile duct cancer. It aims to see if this approach can shrink tumors and improve survival.
This trial tests if a liver transplant can help people with a certain type of bile duct cancer (intrahepatic cholangiocarcinoma) that cannot be removed by surgery. Before the transplant, you would receive radiation therapy (SIRT) and chemotherapy to shrink the tumor.
This trial studies liver transplantation to treat a specific bile duct cancer (perihilar cholangiocarcinoma) that cannot be removed by surgery. It aims to see if a transplant can help when standard chemotherapy has kept the cancer stable.
This trial studies liver transplantation for people with a specific type of bile duct cancer near the liver that cannot be safely removed by surgery. It aims to improve outcomes by offering a transplant after the cancer responds to chemotherapy and spread has been ruled out on scans.
This trial tests whether giving a PD-L1 immunotherapy drug with chemotherapy and radiation before a liver transplant can help people with advanced bile duct cancer. The goal is to shrink the tumor and make a transplant possible.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.